Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.

Published April 28, 2022 | Version v6

Dataset Open

Notes

funded by the Federal Ministry of Education and Research, Germany (NaFoUniMedCovid19, funding number: 01KX2021; part of the project "CEOSys"

Name	Size	Download all
2021-06-07_RoB2 assessments for Cochrane Reviews Systemic corticosteroids for the treatment of COVID-19.xlsm md5:b375a1d11b52f8c4b9963afadeaf6e13	702.3 kB	Download
2021-07-09_RoB2 assessments for Cochrane Reviews Systemic corticosteroids for the treatment of COVID-19.xlsm md5:e4741e9e280640171e0888dbb6efa08d	706.9 kB	Download
2021-07-12_RoB2 assessments for Cochrane Reviews Systemic corticosteroids for the treatment of COVID-19.xlsm md5:c4acc979c7282f166d28a0e8aa896d73	707.2 kB	Download
2021-08-03_RoB2 assessments for Cochrane Reviews Systemic corticosteroids for the treatment of COVID-19.xlsm md5:0e71696e58375eb646ecbf0434a02470	707.0 kB	Download
2022-04-28_RoB2 assessments for Cochrane Reviews Update Systemic corticosteroids for the treatment of COVID-19.xlsm md5:7fb205abeea8d2bec039edd00f230336	715.5 kB	Download